Abstract | OBJECTIVES: METHODOLOGY: This was a randomized controlled clinical trial. Complete clinical data were analyzed from 100 patients (27 men and 73 women; mean age 52.16 ± 13.2 years, range 11-80 years) with BPPV who underwent succcessful repositioning maneuvers and then received betahistine, trimetazidine, gingko biloba extract, or no medication (n = 25 for each group) for 1 week. On days 1, 3, and 5 after the repositioning maneuver, scores obtained from the Dizziness Handicap Inventory (DHI) questionnaire were compared. RESULTS: There were no statistically significant differences in the premedication DHI scores of patients with residual dizziness among the four groups (p > 0.005). After 3 and 5 days of treatment, the mean DHI scores of the groups receiving medication did not differ significantly from the the mean DHI score of the control group (p > 0.005). CONCLUSIONS:
|
Authors | B Acar, R M Karasen, Y Buran |
Journal | B-ENT
(B-ENT)
Vol. 11
Issue 2
Pg. 117-21
( 2015)
ISSN: 1781-782X [Print] Belgium |
PMID | 26563011
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Plant Extracts
- Vasodilator Agents
- Trimetazidine
- Betahistine
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Benign Paroxysmal Positional Vertigo
(therapy)
- Betahistine
(therapeutic use)
- Child
- Combined Modality Therapy
- Dizziness
(therapy)
- Female
- Ginkgo biloba
- Humans
- Male
- Middle Aged
- Patient Positioning
(methods)
- Phytotherapy
- Plant Extracts
(therapeutic use)
- Treatment Outcome
- Trimetazidine
(therapeutic use)
- Vasodilator Agents
(therapeutic use)
- Young Adult
|